Synonyms: IFN-alpha-2 | interferon alpha-2 | Roferon A®
IFN-α2 is an approved drug (FDA (1989))
Compound class:
Endogenous peptide in human, mouse or rat
Comment: IFN-α2 is a type I IFN. The sequence of the recombinant peptide used clinically and known as interferon alfa-2a, is identical to that of human IFN-α2. Interferon alfa-2a has anti-viral, immunomodulatory and antineoplastic actions.
Pegylated IFN alfa 2a is on the World Health Organization's List of Essential Medicines. Click here to access the pdf version of the WHO's 21st Essential Medicines list (2019).
Species: Human
|
For advanced searching click here to open chemical structure editor
Other Similar Sequences ![]() |
|
IFN-α1/13 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α10 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α14 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α16 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α17 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α21 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α4 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α5 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α6 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α7 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α8 {Sp: Human} |
TargetsInterferon-α/β receptor |
peginterferon alfa-2b |
TargetsInterferon-α/β receptor; interferon α/β receptor 1 |
IFN-α2b (recombinant human) |